Not every fever is Covid; swine flu and dengue on the prowl too: NIV – ET HealthWorld

Pune: Unlike the past three waves of the pandemic, when fever — in most cases — meant Covid, the current period is a mixed bag of seasonal viruses and SARS-CoV-2, experts have said. Scientists from ICMR-NIV said seasonal viruses, including H1N1 (swine flu) and H3N2, are now co-circulating with SARS-CoV-2. Dengue cases are also up, an NIV scientist said. “It’s an overlapping season of flu, SARS-CoV-2 and other respiratory viruses. Not every fever means Covid now. Our study clearly shows that,” the scientist said. Jehangir Hospital‘s infectious diseases expert Dr…

Read More

Kolkata: Covid less severe in dengue zones, says study – ET HealthWorld

KOLKATA: Ongoing research by an Indian Institute of Chemical Biology (IICB) scientist in Kolkata has indicated that the severity of Covid has been less in dengue-prone areas. In April 2020, CSIR-Indian Institute of Chemical Biology (IICB) virologist Subhajit Biswas coined the term, “Dengue Covid Conundrum” talking about how Covid-19 severity and mortality were observably less in highly dengue-endemic countries, including India. Over the last two years, international scholars focused on the questions posed by Biswas: is pre-exposure to dengue protective against Covid and vice-versa; and can dengue vaccines be repurposed…

Read More

Sanofi, GSK variant-specific COVID shot found effective against Omicron – ET HealthWorld

By Natalie Grover Paris/London: Late-stage data on an experimental COVID-19 vaccine from Sanofi and GSK has showed the shot confers protection against the Omicron variant of the virus, the companies said on Friday. The so-called bivalent vaccine targets the Beta variant – first identified in South Africa – as well as the original Wuhan strain of the virus. In a trial involving 13,000 adults, the vaccine demonstrated an efficacy rate of 64.7% against symptomatic COVID, and 72% efficacy against infections specifically caused by the Omicron variant. When used in people…

Read More

BRICS nations stress on equitable distribution of Covid vaccines to fill immunisation gap globally – ET HealthWorld

New Delhi: Stressing on equitable distribution of vaccines and expeditious inoculation to combat COVID-19, leaders of the BRICS nations on Thursday said they recognise the importance of the discussions in the WTO on the relevant intellectual property waiver proposals as well as on capacity building and strengthening local production of jabs, especially in developing countries. Prime Minister Narendra Modi participated in the virtual BRICS summit, along with Chinese President Xi Jinping, Russian President Vladimir Putin and top leaders of Brazil and South Africa. The summit is being hosted by China…

Read More

Health Minister to hold review meeting to discuss rising Covid cases – ET HealthWorld

New Delhi: Union Health Minister Mansukh Mandaviya will chair a review meeting on Thursday to discuss the spike in the number of Covid cases in the country. According to a source, Mandaviya will review the Covid situation with the core team of experts at the meeting. India has been witnessing a spike in daily Covid cases for the past few days. After a decline on Tuesday, India again reported a rise on Wednesday with 12,249 fresh Covid infections. During the same period, the country also reported 13 Covid deaths, taking…

Read More

India logs 7,584 Covid cases, 24 more deaths in a day – ET HealthWorld

New Delhi: India‘s COVID-19 case tally rose by 7,584 in a day to reach 4,32,05,106 while the number of active cases has increased to 36,267, according to Union Health Ministry data updated on Friday. The death toll has climbed to 5,24,747 with 24 more fatalities, the data updated at 8 am stated. Active case tally increased by 3,769 and now comprise 0.08 per cent of the total infections, while the national COVID-19 recovery rate was recorded at 98.70 per cent, the health ministry said. The daily positivity rate was recorded…

Read More

Covid billing: Private hosps told to stick to 80:20 scheme – ET HealthWorld

Mumbai: Patients seeking admission in private hospitals for Covid-19 will be charged as per the 80:20 scheme that was brought in by the state government to regulate treatment charges during the first wave. Under the scheme, hospitals are supposed to charge government-fixed rates for 80% of their total Covid beds. They are at liberty to charge their own rates for the remaining 20% beds. Dr Sudhakar Shinde, who was instrumental in designing the scheme, said 80:20 will remain applicable till further orders. On Monday, BMC held a meeting with private…

Read More

Amid rise in COVID cases, ICMR issues guidelines for management of type 1 diabetes – ET HealthWorld

New Delhi: Indian Council for Medical Research (ICMR) on Monday issued guidelines for the management of type 1 Diabetes. The guidelines are released by Prof. (Dr) Balram Bhargava, Secretary-DHR and DG-ICMR. The guidelines have mentioned about the burden of diabetes increased among the young population in India, type 1 diabetes is commonest in children and adolescents, and challenges exist in providing equitable treatment. Diabetic complications can be reduced with improved control measures and better management leads to improved quality of life. Dr Nikhil Tandon, Head of the department of endocrinology,…

Read More

Amid rising COVID cases, top scientist calls for ramping up genome sequencing – ET HealthWorld

By Shalini Bhardwaj New Delhi: As India reported its biggest jump in three months on Monday – an increase of 1,730 active COVID cases in a span of 24 hours – the Director of Tata Institute of Genetics and Society (TIGS) Dr Rakesh Mishra called for increasing genome sequencing, despite the “severity of the disease being extremely low”. In an exclusive interview with ANI, Dr Mishra said, “Omicron and its sub-lineages can reinfect any vaccinated person and/or the ones who have had a natural infection and so on. The severity…

Read More

Test makers target monkeypox market as cases surge – ET HealthWorld

London: Diagnostic companies are racing to develop tests for monkeypox, hoping to tap into a new market as governments ramp up efforts to trace the world’s first major outbreak of the viral infection outside of Africa. The scramble started last month, much like early 2020 when companies rushed to make kits to help diagnose COVID-19, creating a multibillion-dollar boon for test makers. But demand for monkeypox tests will be a fraction of what it was for COVID, given monkeypox is not as transmissible nor as dangerous as COVID – it…

Read More